The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Counterfeit Drug Detection in the Pharmaceutical Industry Using Blockchain
|
|
Author(s): Avdhesh Kumar Tiwari (ABES Institute of Technology, Ghaziabad, India), Ashish Kumar (Central Pollution Control Board, Delhi, India), Vanshika Agarwal (ABES Institute of Technology, Ghaziabad, India), Shivam Rajput (ABES Institute of Technology, Ghaziabad, India)and Shubham Singh (ABES Institute of Technology, Ghaziabad, India)
Copyright: 2024
Pages: 15
Source title:
Enhancing Medical Imaging with Emerging Technologies
Source Author(s)/Editor(s): Avinash Kumar Sharma (Sharda University, India), Nitin Chanderwal (University of Cincinnati, USA), Shobhit Tyagi (Sharda University, India), Prashant Upadhyay (Sharda University, India)and Amit Kumar Tyagi (National Institute of Fashion Technology, New Delhi, India)
DOI: 10.4018/979-8-3693-5261-8.ch009
Purchase
|
Abstract
Counterfeit drugs pose a significant threat to public health and patient safety, with the World Health Organization estimating that 10% of the global pharmaceutical market consists of fake medications. This study proposes a novel solution to combat counterfeit pharmaceuticals by leveraging blockchain technology. By establishing a secure and transparent health data network, the proposed approach aims to detect and prevent the distribution and consumption of counterfeit medicines effectively. Through the implementation of blockchain technology, a robust and trustworthy pharmaceutical supply chain can be created, enabling the tracking of drugs from manufacturing to patient consumption. This not only facilitates the immediate identification of counterfeit drugs but also impedes their further distribution. By integrating blockchain technology into the drug supply chain, stakeholders can verify the authenticity of pharmaceutical products and ensure patient safety. Moreover, the use of blockchain enhances transparency and accountability by integrating disparate databases and stakeholders.
Related Content
|
Aylin Gökhan, Kubilay Dogan Kilic, Türker Çavuşoğlu, Yiğit Uyanıkgil.
© 2024.
12 pages.
|
|
Pratyush Panda, Subhalaxmi Das.
© 2024.
21 pages.
|
|
Vikram Singh, Sangeeta Rani.
© 2024.
17 pages.
|
|
Pancham Singh, Mrignainy Kansal, Shirshendu Lahiri, Harshit Vishnoi, Lakshay Mittal.
© 2024.
19 pages.
|
|
Shreeharsha Dash, Subhalaxmi Das.
© 2024.
16 pages.
|
|
V. Sathya, Shalini Parthiban, M. Megavarshini, V. Shenbagaraman, R. Ramya.
© 2024.
13 pages.
|
|
Olalekan Joel Awujoola, Theophilus Enem Aniemeka, Oluwasegun Abiodun Abioye, Abidemi Elizabeth Awujoola, Fiyinfoluwa Ajakaiye, Olayinka Racheal Adelegan.
© 2024.
34 pages.
|
|
|